To promote the equitable access and utilisation of the HPV vaccine in Nigeria, the HPV vaccination policy-research program aims to generate evidence to support HPV vaccine introduction and uptake in Nigeria and facilitate the dissemination, adoption, and implementation of research findings, with a timeline of 21 months from February 2023 to November 2024.

Cervical cancer is a significant public health concern, especially in Nigeria, where it is a leading cause of cancer-related deaths among women. Human papillomavirus (HPV) is the primary cause of cervical cancer, and vaccination is a safe and effective strategy for preventing it.

The overall goal of this project is to ensure that at least 90% of girls in Nigeria receive the HPV vaccine by age 15. The research project will be carried out in three phases, which include a dissemination workshop, research program, and close-out workshop.

The research activities will involve stakeholder mapping, data collection, analysis, and the development of a dissemination plan to ensure that the research findings are widely disseminated and utilised to influence policy and executive action towards successful HPV vaccine introduction and utilisation in Nigeria.